NYXH announces U.S. ACCCESS pivotal study meets safety, efficacy endpoints
NYXOAH said its ACCCESS U.S. pivotal study met primary safety and efficacy endpoints in complete concentric collapse patients.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.